Mon, Mar 2, 2015, 8:58 AM EST - U.S. Markets open in 32 mins.


% | $
Quotes you view appear here for quick access.

SIGA Technologies, Inc. Message Board

spectrollmicro 11 posts  |  Last Activity: Jan 15, 2015 6:20 PM Member since: Dec 29, 2014
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • spectrollmicro spectrollmicro Jan 15, 2015 6:20 PM Flag

    I like the daily penalty Chancery Parsons issued. That should have been done years ago, but I guess he just got fed up at this point with the entire refiguring interest.

    Actually Siga is making out quite well with this nominal dollar figure decision. They get to pay about $125 million less with this new decision.

    Sentiment: Strong Buy

  • spectrollmicro spectrollmicro Jan 15, 2015 6:14 PM Flag

    teebrane you are correct on every point you just made. I look for the SC to essentially just take a quick look and say sorry no appeal, pay up.

    Then the Bankruptcy Court can tell Siga they can afford the award to their one and only real creditor and bankruptcy protection denied and Siga stock then goes to zero for all I care.

    Sentiment: Strong Buy

  • spectrollmicro spectrollmicro Jan 13, 2015 1:43 PM Flag

    Probably the billion potential isn't causing a share price appreciation because the daytraders care not and they are happy with their pennies each day and selling at whatever price gives them the slightest profit. They care not that it could go to $8 because they are willing to lock in $.10 short term gain and pay 15% tax on that dime they think they just made.

    So there is the slightest bit of advantage to that short term thinking until they sell and an overwhelming amount of buying comes in right after their sell and drives the price up without them. They miss the big money to get the little money, but their little brains can't comprehend the thought of investing for long term.

    Sentiment: Strong Buy

  • Reply to


    by coveman2000 Jan 8, 2015 4:57 PM
    spectrollmicro spectrollmicro Jan 9, 2015 2:26 PM Flag

    I have to say, I find it amazing so many institutions are still invested in Siga. while under the overhang of Chapter 11 and continuous negative judgements. This is back dropped by a decrease in ST246 demand by BARDA.

    Talk about risky bets in the stock market. I try to imagine how they can legitimize the investment to their superiors and investors. The Siga shareholders have better chance of being wiped out than seeing a significant appreciation in the share price. All the while, institutions invested in PharmAthene have not really expanded their investment all that much, while it sees positive judgements worth $200 million that could easily finance an acquisition and future expansion in pipeline.

    Sentiment: Strong Buy

  • spectrollmicro spectrollmicro Jan 8, 2015 8:59 AM Flag

    If the case gets back to the Delaware Supreme Court, the court can deny and not even hear the case. That action would make the Chancery decision final. This is more likely, but if the SC were to hear the case again, SIGA still gets to pay and probably more than the Chancery has said.

    By the way, interest keeps on multiplying and PharmAthene legal fees are being paid for by SIGA as that accumulates as well.

    Sentiment: Strong Buy

  • Reply to

    Appeal will probably be denied

    by spectrollmicro Jan 7, 2015 1:50 PM
    spectrollmicro spectrollmicro Jan 7, 2015 2:35 PM Flag

    Reimbursement for attorney fees and interest on the award has already been confirmed by the Supreme Court and reaffirmed by them. So far every decision has confirmed the award to PharmAthene and somewhere along the line the fantasy world population of the Siga followers and those that deny the reality of the situation, will have to concede facts are facts. That means much money to PharmAthene, like it or not.

    Sentiment: Strong Buy

  • spectrollmicro by spectrollmicro Jan 7, 2015 2:26 PM Flag

    Opinion and Order directing PharmAthene(PIP) to submit a Revised Proposed Judgment that reflects a lump sum award of approximately $113 million in contract expectation damages, plus pre-judgment interest on that amount from 2006 through the date of the letter Opinion and Order, for the value of PharmAthene's(PIP) lost profits for SIGA's smallpox antiviral, Tecovirimat. The total award when finalized, including interest and reimbursement of a portion of PharmAthene's(PIP) attorneys' and expert witness fees, is estimated to be in excess of $190 million.

    Sentiment: Strong Buy

  • spectrollmicro by spectrollmicro Jan 7, 2015 1:50 PM Flag

    The margin of argument now is a couple million and the Supreme Court won't bother to hear the case again.

    Sentiment: Strong Buy

  • Reply to

    it didn't seem to bother shorts

    by spectrollmicro Jan 7, 2015 1:01 PM
    spectrollmicro spectrollmicro Jan 7, 2015 1:35 PM Flag

    I think the point made on page 3, note 1, of the opinion regarding what Siga submits as an appropriate lump sum to PharmAthene's expectation of damages at $105,111,021 is a good start and that payment should be made immediately and then discuss the difference after that check has been cashed or transfer of funds this week.

    Sentiment: Strong Buy

  • spectrollmicro by spectrollmicro Jan 7, 2015 1:01 PM Flag

    no rush to cover based on history. However, I agree this takes the SIGA BK thought process and shoots big holes in that argument to allow a BK. PIP should trade in the high $2 -$3.75 range this week. Maybe the institutions will start to take a larger position.

    Sentiment: Strong Buy

  • Reply to

    Just The Facts N=1

    by irishtrader52 Dec 29, 2014 12:53 PM
    spectrollmicro spectrollmicro Dec 29, 2014 12:57 PM Flag

    Well done Irish! Good luck to John and your family for a good New Year.

2.27+0.03(+1.34%)Feb 27 4:00 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.